Artificial intelligence models have a valuable role to play in each phase of the total testing process.
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Approval for OTC use of a urine drug test that can be performed by non-CLIA facilities could help expand accessibility, expert says.
Accessible screening tests and inclusive management strategies may limit the global cervical cancer incidence rate.
New program aims to provide greater transparency on the recommended performance characteristics of such tests.
Multiorgan analysis of biobank data elucidates heart–brain links that could enhance disease prevention and detection.
The agency recently announced it will decide in December whether to grant clearance for a CRISPR therapy for treating sickle cell disease.
Automation software uses advanced computational tools to generate gapless genome sequences in just a couple of days.
Although PRS technology and adoption still have a way to go, it is progressing quickly, especially in the cancer and oncology space.
Free open-source software can be leveraged across diagnostic processes—how can your organization benefit from it?
Christian Olsen, a leader in R&D scientific software, discusses recent developments related to AI and solutions to current precision medicine challenges.
In early May, GSK’s Arexvy became the first RSV vaccine to be cleared by the FDA for use in the US in adults aged 60 and up.
AAV2 virus detected with metagenomics, TE sequencing, and PCR in non-A–E hepatitis cases from two cohorts in Scotland/the UK and the US.